Published 09/27/2024 3:08:48 p.m.

SMT’s Supraflex Cruz DES Approved in Australia - Cardiac Interventions Today

Summary by Cardiac Interventions Today

September 27, 2024— Sahajanand Medical Technology Pvt Ltd (SMT), which is based in Mumbai, India, announced that its flagship drug-eluting stent (DES), Supraflex Cruz, has received regulatory approval from the Therapeutic Goods Administration in Australia for the treatment of coronary artery disease. According to SMT, the Supraflex Cruz DES is designed to deliver a combination of sirolimus and a biodegradable polymer that ensures optimal drug re…

0 Articles

0 Articles

All

Left

Center

Right

Cardiac Interventions Today

SMT’s Supraflex Cruz DES Approved in Australia - Cardiac Interventions Today

September 27, 2024— Sahajanand Medical Technology Pvt Ltd (SMT), which is based in Mumbai, India, announced that its flagship drug-eluting stent (DES), Supraflex Cruz, has received regulatory approval from the Therapeutic Goods Administration in Australia for the treatment of coronary artery disease. According to SMT, the Supraflex Cruz DES is designed to deliver a combination of sirolimus and a biodegradable polymer that ensures optimal drug re…

09/27/2024 3:08:48 p.m.

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated09/28/2024 1:16:58 a.m.Bias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics

Trending Topics

Donate Privacy Policy Manage Cookies Terms and Conditions

© 2024 Snapwise Inc